20/20 BioLabs to Host November 4 Investor Webinar on OneTest™ Commercial Expansion and Growth Strategy
Globe Newswire•29/10/2026•09:37 ET
0
Key Highlights
- ➤20/20 BioLabs (AIDX) schedules November 4 webinar on OneTest commercial expansion
- ➤2027 licensing plans target U.S. and international clinical laboratories
- ➤Potential acquisitions may expand OneTest customers across health and cancer-detection businesses
- ➤Maryland firefighter screening awards exceeded $520,000 across 18 fire-department groups
- ➤Medicare reimbursement goal targets MCED coverage by end of 2028
Expert Statements
Jonathan Cohen, President and Chief Executive Officer of 20/20 BioLabs
“Our goal is to expand the reach of OneTest by working with established laboratories, licensing our technology, and pursuing acquisitions that could bring additional customers onto our testing platform”
Jonathan Cohen, President and Chief Executive Officer of 20/20 BioLabs
“On November 4, I look forward to discussing how these initiatives could support our growth in 2027, along with our FDA planning and the opportunities we see to expand state-funded firefighter cancer screening programs.”
CEO Jonathan Cohen to Discuss Laboratory Franchise Model, 2027 Licensing Plans, Potential Acquisitions, FDA Strategy, and Firefighter Cancer Screening Initiatives
Webinar to Be Held Wednesday, November 4, 2026 at 12:00 p.m. Eastern Time; Registration Is Now Open
Get started
Create a free account to read the full story.